Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stem-Cell-Derived Biologic Ventricular Assist Tissue in Heart Failure.

The New England journal of medicine·2026
Same author

Targeting Interleukin-8-Mediated Cellular Crosstalk Reverses Hypertrophic Cardiomyopathy and Cardiac Fibrosis in Noonan Syndrome.

Circulation·2026
Same author

Enhancing KLF15 activity in cardiomyocytes: a novel approach to prevent pathological reprogramming and fibrosis via nuclease-deficient dCas9VPR.

Signal transduction and targeted therapy·2026
Same author

Protocol for differentiation of vascular smooth muscle cells from human iPSCs and their application in CRISPRa-mediated gene regulation.

STAR protocols·2026
Same author

In memory of Professor Thomas Wieland (1960-2025).

Naunyn-Schmiedeberg's archives of pharmacology·2025
Same author

Cardiac fibrosis inhibitor CTPR390 prevents structural and morphological changes in human engineered cardiac connective tissue.

iScience·2025

Related Experiment Video

Updated: Oct 21, 2025

Fibroblast Derived Human Engineered Connective Tissue for Screening Applications
09:50

Fibroblast Derived Human Engineered Connective Tissue for Screening Applications

Published on: August 20, 2021

3.7K

Fibroblast Derived Human Engineered Connective Tissue for Screening Applications.

Gabriela L Santos1, Tim Meyer2, Malte Tiburcy2

  • 1Institute of Pharmacology and Toxicology, University Medical Center Goettingen; DZHK (German Center for Cardiovascular Research) partner site, Goettingen; gabriela.santos@med.uni-goettingen.de.

Journal of Visualized Experiments : Jove
|September 6, 2021
PubMed
Summary
This summary is machine-generated.

This study presents a reproducible method for creating engineered connective tissues (ECT) to study fibroblast behavior and fibrosis. This 3D model allows for controlled biomechanical loading to investigate fibrotic processes.

More Related Videos

Fibroblast-Derived 3D Matrix System Applicable to Endothelial Tube Formation Assay
07:21

Fibroblast-Derived 3D Matrix System Applicable to Endothelial Tube Formation Assay

Published on: December 26, 2019

7.7K
Engineering Fibrin-based Tissue Constructs from Myofibroblasts and Application of Constraints and Strain to Induce Cell and Collagen Reorganization
12:13

Engineering Fibrin-based Tissue Constructs from Myofibroblasts and Application of Constraints and Strain to Induce Cell and Collagen Reorganization

Published on: October 28, 2013

11.0K

Related Experiment Videos

Last Updated: Oct 21, 2025

Fibroblast Derived Human Engineered Connective Tissue for Screening Applications
09:50

Fibroblast Derived Human Engineered Connective Tissue for Screening Applications

Published on: August 20, 2021

3.7K
Fibroblast-Derived 3D Matrix System Applicable to Endothelial Tube Formation Assay
07:21

Fibroblast-Derived 3D Matrix System Applicable to Endothelial Tube Formation Assay

Published on: December 26, 2019

7.7K
Engineering Fibrin-based Tissue Constructs from Myofibroblasts and Application of Constraints and Strain to Induce Cell and Collagen Reorganization
12:13

Engineering Fibrin-based Tissue Constructs from Myofibroblasts and Application of Constraints and Strain to Induce Cell and Collagen Reorganization

Published on: October 28, 2013

11.0K

Area of Science:

  • Biomedical Engineering
  • Cell Biology
  • Tissue Engineering

Background:

  • Fibroblasts dynamically transdifferentiate into myofibroblasts in response to stimuli.
  • Poor understanding of fibrotic processes, like cardiac fibrosis, hinders anti-fibrotic therapy development.
  • Reliable human model systems are essential for studying fibrosis pathology.

Purpose of the Study:

  • To develop a reproducible and scalable protocol for generating engineered connective tissues (ECT).
  • To create a 3D in vitro model system for studying fibroblast behavior and fibrotic tissue pathophysiology.
  • To enable investigations into cell-matrix interactions and phenotypic adaptations under defined biomechanical loads.

Main Methods:

  • Generation of ECT in a 48-well casting plate around poles with tunable stiffness.
  • Application of defined biomechanical loading conditions to the engineered tissues.
  • Parallel testing and time-course analysis of tissue compaction, contraction, stiffness, and elasticity.

Main Results:

  • A highly reproducible and scalable protocol for generating 3D engineered connective tissues (ECT).
  • The ability to study fibroblast phenotypic adaptations under controlled biomechanical loading and cell-matrix interactions.
  • Feasibility of parallel testing and time-course analysis of multiple biomechanical parameters.

Conclusions:

  • The developed engineered connective tissue (ECT) model provides a valuable tool for studying fibroblast behavior and fibrotic processes in a 3D environment.
  • This model facilitates research into the pathophysiology of fibrotic diseases and the development of novel anti-fibrotic therapies.
  • The 48-well format enables high-throughput screening and detailed biomechanical characterization of engineered tissues.